Corteva, Inc. CTVA
78.52
(0.93)
(1.17%)
as of 25 Sep
- Market cap
- $53.0B
- P/E
- 52.0×
Follow CTVA
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
28.90 | 42.42 | 49.24 | 56.09 |
P/S ratio |
2.63 | 2.62 | 3.15 | 3.18 | |
P/FCF ratio |
17.11 | 15.89 | 26.91 | 85.92 | |
P/Operating CF |
237.83 | 10.42 | (19.47) | (121.51) | |
P/B ratio |
1.80 | 1.87 | 2.29 | 2.23 | |
Price to Tangible BV |
7.04 | 8.11 | 9.31 | 8.14 | |
EV/Sales |
2.73 | 2.51 | 3.22 | 3.32 | |
EV/EBITDA |
12.89 | 14.21 | 18.34 | 19.71 | |
EV/Operating CF |
14.88 | 12.81 | 21.98 | 48.83 | |
EV/FCF |
17.77 | 15.21 | 27.57 | 89.73 | |
Quick Ratio |
1.00 | 0.90 | 0.93 | 1.03 | |
Current Ratio |
1.58 | 1.43 | 1.47 | 1.52 | |
Net Debt/EBITDA |
(74.46) | 10.96 | 1.17 | 1.25 | |
Debt/Assets |
10.36% | 6.02% | 7.86% | 11.71% | |
Debt/Equity |
0.17 | 0.11 | 0.14 | 0.19 | |
Asset Turnover |
0.42 | 0.42 | 0.42 | 0.43 | |
Operating CF/Net income |
(0.60) | (7.93) | (4.02) | (0.40) | |
Capex/Depreciation |
(0.52) | (0.63) | (0.27) | (0.36) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
13.41% | 10.56% | 6.95% | 6.08% | |
Selling, General and Administrative Expense of Revenue |
27.69% | 21.99% | 17.88% | 18.25% | |
Intangible Assets out of Total Assets |
0.45 | 0.44 | 0.43 | 0.44 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(0.01) | (0.02) | (0.01) | 0.00 | |
Graham Number |
44.44 | 35.71 | 37.41 | 35.93 | |
Earnings Yield |
3.46% | 2.36% | 2.03% | 1.78% | |
Free Cash Flow Yield |
5.85% | 6.29% | 3.72% | 1.16% | |
Revenue per Share |
3.86 | 5.75 | 7.29 | 9.54 | |
Operating CF per Share |
0.28 | 6.43 | (4.30) | (0.70) | |
Capex per Share |
(0.23) | (0.29) | (0.12) | (0.18) | |
Free Cash Flow per Share |
0.05 | 6.15 | (4.42) | (0.88) | |
Cash per Share |
3.81 | 6.66 | 2.92 | 3.54 | |
Shareholders Equity per Share |
37.51 | 35.86 | 36.59 | 37.99 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
37.51 | 35.86 | 36.59 | 37.99 | |
Free Cash Flow |
37.00 | 4,181.00 | (2,972.00) | (587.00) | |
Working Capital |
6,018.00 | 5,210.00 | 5,531.00 | 5,568.00 | |
Capital Expenditures |
(156.00) | (194.00) | (81.00) | (121.00) | |
Net Current Asset Value |
(299.00) | (1,124.00) | (727.00) | 118.00 | |
EV/EBIT |
19.08 | 23.36 | 29.70 | 33.64 | |
Capex to Sales |
0.06 | 0.05 | 0.02 | 0.02 | |
Net Profit Margin |
(12.22%) | (14.12%) | 14.68% | 18.20% | |
Price to Operating Income |
18.36 | 24.40 | 28.99 | 32.21 | |
| Other line items | |||||
Average Receivables |
7,217.50 | 6,023.50 | 8,691.00 | 8,685.00 | |
Average Payables |
4,045.00 | 4,218.50 | 4,046.00 | 3,893.00 | |
Average Inventory |
5,492.00 | 5,549.50 | 5,167.00 | 4,379.50 | |
Average Assets |
42,053.00 | 41,835.00 | 42,420.00 | 41,700.50 | |
Average Common Equity |
25,220.00 | 24,208.00 | 24,566.00 | 25,777.00 |
Columns are period end dates